Tech Transfer eNews Blog

Mayo Clinic creates platform to share clinical data with drug developers

By Jesse Schwartz
Published: January 22nd, 2020

The Mayo Clinic has created a data analytics platform to speed the development of promising and innovative new drugs.

The new platform is a “mechanism by which the data of the past can be used to improve the care of the future,” says John Halamka, president of Mayo Clinic Platform, a program launched last year to support projects aimed at boosting drug development.

The platform is designed to make the process of discovering and sharing historical clinical data more efficient, particularly for collaborators from outside the Mayo system. Currently, it can take health systems more than a year to get that kind of partnership up and running.

The first outside collaborator on the new platform is Nference, a software start-up that Mayo is an investor in. Under the partnership, researchers from both the start-up and the clinic will apply Nference’s analytics tools to data discovered in the new Mayo platform to draw out insights, such as biomarkers for new drugs.

Mayo Clinic says it plans to work with pharmaceutical companies to commercialize new therapies. The health system wouldn’t take the drugs to market itself, but it could receive royalties from insights gathered from the clinical data platform.

Source: Modern Healthcare

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment